2,460
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Activated brown adipose tissue and its relationship to adiposity and metabolic markers: an exploratory study

, , , , , ORCID Icon, & show all
Pages 87-95 | Received 04 Oct 2019, Accepted 27 Jan 2020, Published online: 11 Feb 2020

References

  • Hales CM, Fryar CD, Carroll MD, et al. Differences in obesity prevalence by demographic characteristics and urbanization level among adults in the United States, 2013–2016. JAMA. 2018;319(23):2419–2429. Epub 2018/06/21. PubMed PMID: 29922829.
  • Kajimura S, Saito M. A new era in brown adipose tissue biology: molecular control of brown fat development and energy homeostasis. Annu Rev Physiol. 2014;76:225–249. Epub 2013/ 11/06. PubMed Central PMCID: PMCPMC4090362.
  • Yoneshiro T, Aita S, Matsushita M, et al. Brown adipose tissue, whole-body energy expenditure, and thermogenesis in healthy adult men. Obesity. 2010;19(1):13–16.
  • Chondronikola M, Volpi E, Børsheim E, et al. Brown adipose tissue improves whole-body glucose homeostasis and insulin sensitivity in humans. Diabetes. 2014;63(12):4089–4099. PubMed PMID: PMC4238005
  • Hibi M, Oishi S, Matsushita M, et al. Brown adipose tissue is involved in diet-induced thermogenesis and whole-body fat utilization in healthy humans. Int J Obes. 2016;40:1655–1661.
  • Stanford KI, Middelbeek RJW, Townsend KL, et al. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J Clin Invest. 2013;123(1):215–223. PubMed PMID: PMC3533266
  • Lundström E, Ljungberg J, Andersson J, et al. Brown adipose tissue estimated with the magnetic resonance imaging fat fraction is associated with glucose metabolism in adolescents. Pediatr Obes. 2019;14(9):e12531.
  • Matsushita M, Yoneshiro T, Aita S, et al. Impact of brown adipose tissue on body fatness and glucose metabolism in healthy humans. Int J Obes. 2014;38:812–817.
  • Van Marken Lichtenbelt W, Vanhommerig J, Smulders N, et al. Cold-activated brown adipose tissue in healthy men. N Engl J Med. 2009;360:1500–1508.
  • Vijgen G, Bouvy N, Jaap Teule G, et al. Brown adipose tissue in morbidly obese subjects. PloS ONE. 2011;6(2):e17247.
  • Lee P, Brychta RJ, Linderman J, et al. Mild cold exposure modulates fibroblast growth factor 21 (FGF21) diurnal rhythm in humans: relationship between FGF21 levels, lipolysis, and cold-induced thermogenesis. J Clin Endocrinol Metab. 2013;98(1):E98–102. Epub 2012/ 11/15. PubMed Central PMCID: PMCPMC3537100.
  • Hondares E, Iglesias R, Giralt A, et al. Thermogenic activation induces FGF21 expression and release in brown adipose tissue. J Biol Chem. 2011;286(15):12983–12990. PubMed PMID: PMC3075644.
  • Burýšek L, Houštěk J. β-Adrenergic stimulation of interleukin-1α and interleukin-6 expression in mouse brown adipocytes. FEBS Lett. 1997;411(1):83–86.
  • Lee P, Linderman Joyce D, Smith S, et al. Irisin and FGF21 Are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 2014;19(2):302–309.
  • BonDurant LD, Ameka M, Naber MC, et al. FGF21 regulates metabolism through adipose-dependent and -independent mechanisms. Cell Metab. 2017;25(4):935–44.e4.
  • Owen BM, Ding X, Morgan DA, et al. FGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss. Cell Metab. 2014;20(4):670–677.
  • Coskun T, Bina HA, Schneider MA, et al. Fibroblast growth factor 21 corrects obesity in mice. Endocrinology. 2008;149(12):6018–6027.
  • Talukdar S, Zhou Y, Li D, et al. A long-acting FGF21 molecule, PF-05231023, decreases body weight and improves lipid profile in non-human primates and type 2 diabetic subjects. Cell Metab. 2016;23(3):427–440.
  • Gaich G, Chien JY, Fu H, et al. The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. Cell Metab. 2013;18(3):333–340.
  • Lidell ME, Betz MJ, Leinhard OD, et al. Evidence for two types of brown adipose tissue in humans. Nat Med. 2013;19(5):631–634.
  • Harms M, Seale P. Brown and beige fat: development, function and therapeutic potential. Nat Med. 2013;19(10):1252–1263. Epub 2013/ 10/09. PubMed PMID: 24100998.
  • Giralt M, Villarroya F. White, brown, beige/brite: different adipose cells for different functions? Endocrinology. 2013;154(9):2992–3000. Epub 2013/ 06/21. PubMed PMID: 23782940.
  • Hanssen MJ, Wierts R, Hoeks J, et al. Glucose uptake in human brown adipose tissue is impaired upon fasting-induced insulin resistance. Diabetologia. 2015;58(3):586–595. Epub 2014/ 12/17. PubMed PMID: 25500952.
  • Landsberg L. Feast or famine: the sympathetic nervous system response to nutrient intake. Cell Mol Neurobiol. 2006;26(4–6):497–508.
  • Bianco AC, McAninch EA. The role of thyroid hormone and brown adipose tissue in energy homoeostasis. Lancet Diabetes Endocrinol. 2013;1(3):250–258. Epub 2014/ 03/14. PubMed PMID: 24622373; PubMed Central PMCID: PMCPMC4976626.
  • de Jesus LA, Carvalho SD, Ribeiro MO, et al. The type 2 iodothyronine deiodinase is essential for adaptive thermogenesis in brown adipose tissue. J Clin Invest. 2001;108(9):1379–1385. Epub 2001/11/07. PubMed PMID: 11696583; PubMed Central PMCID: PMCPMC209445.
  • van der Lans A, Wierts R, Vosselman M, et al. Cold-activated brown adipose tissue in human adults: methodological issues. Am J Physiol Regul Integr Comp Physiol. 2014;307(2):R103–13.
  • Virtanen KA, Lidell ME, Orava J, et al. Functional brown adipose tissue in healthy adults. N Engl J Med. 2009;360(15):1518–1525. Epub 2009/ 04/10.
  • van der Lans AA, Hoeks J, Brans B, et al. Cold acclimation recruits human brown fat and increases nonshivering thermogenesis. J Clin Invest. 2013;123(8):3395–3403. Epub 2013/ 07/23. PubMed Central PMCID: PMCPMC3726172.
  • Deng J, Neff LM, Rubert NC, et al. MRI characterization of brown adipose tissue under thermal challenges in normal weight, overweight, and obese young men. J Magn Reson Imaging. 2018;47(4):936–947.
  • Chen KY, Cypess AM, Laughlin MR, et al. Brown adipose reporting criteria in imaging STudies (BARCIST 1.0): recommendations for standardized FDG-PET/CT experiments in humans. Cell Metab. 2016;24(2):210–222. Epub 2016/08/11. PubMed PMID: 27508870; PubMed Central PMCID: PMCPMC4981083.
  • Wollaeger E, Comfort M, Weir J. The total solids, fat and nitrogen in the feces: II. A study of persons who had undergone partial gastrectomy with anastamosis of the entire cut end of the stomach and the jejunum (Polya anastamosis). Gastroenterology. 1946;6:93–104.
  • Yoneshiro T, Aita S, Matsushita M, et al. Age-related decrease in cold-activated brown adipose tissue and accumulation of body fat in healthy humans. Obesity. 2011;19(9):1755–1760.
  • Lee P, Smith S, Linderman J, et al. Temperature-acclimated brown adipose tissue modulates insulin sensitivity in humans. Diabetes. 2014;63(11):3686–3698. . PubMed PMID: PMC4207391.
  • Markan KR, Naber MC, Ameka MK, et al. Circulating FGF21 is liver derived and enhances glucose uptake during refeeding and overfeeding. Diabetes. 2014;63(12):4057–4063. Epub 2014/ 07/11. PubMed Central PMCID: PMCPMC4238010.
  • Zhang X, Yeung DC, Karpisek M, et al. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans. Diabetes. 2008;57(5):1246–1253. Epub 2008/ 02/07.
  • Dushay J, Chui PC, Gopalakrishnan GS, et al. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. Gastroenterology. 2010;139(2):456–463. Epub 2010/05/11. PubMed PMID: 20451522; PubMed Central PMCID: PMCPMC4862867.
  • Mraz M, Bartlova M, Lacinova Z, et al. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity. Clin Endocrinol. 2009;71(3):369–375. Epub 2009/ 08/26.
  • Cuevas-Ramos D, Almeda-Valdes P, Gomez-Perez FJ, et al. Daily physical activity, fasting glucose, uric acid, and body mass index are independent factors associated with serum fibroblast growth factor 21 levels. Eur J Endocrinol. 2010;163(3):469–477. Epub 2010/06/23. PubMed PMID: 20566587.
  • Lee Y, Lim S, Hong ES, et al. Serum FGF21 concentration is associated with hypertriglyceridaemia, hyperinsulinaemia and pericardial fat accumulation, independently of obesity, but not with current coronary artery status. Clin Endocrinol. 2014;80(1):57–64. Epub 2013/ 01/03.
  • Reinehr T, Woelfle J, Wunsch R, et al. Fibroblast growth factor 21 (FGF-21) and its relation to obesity, metabolic syndrome, and nonalcoholic fatty liver in children: a longitudinal analysis. J Clin Endocrinol Metab. 2012;97(6):2143–2150. Epub 2012/ 03/23.
  • Berti L, Irmler M, Zdichavsky M, et al. Fibroblast growth factor 21 is elevated in metabolically unhealthy obesity and affects lipid deposition, adipogenesis, and adipokine secretion of human abdominal subcutaneous adipocytes. Mol Metab. 2015;4(7):519–527. Epub 2015/07/03. PubMed PMID: 26137439; PubMed Central PMCID: PMCPMC4481465.
  • Gavrilla A, Hasselgren P-O, Glasgow A, et al. Variable cold-induced brown adipose tissue response to thyroid hormone status. Thyroid. 2017;27(1):1–10. PubMed PMID: 27750020
  • Zhang Q, Miao Q, Ye H, et al. The effects of thyroid hormones on brown adipose tissue in humans: a PET-CT study. Diabetes Metab Res Rev. 2014;30(6):513–520.
  • Begaye B, Piaggi P, Thearle MS, et al. Norepinephrine and T4 are predictors of fat mass gain in humans with cold-induced brown adipose tissue activation. J Clin Endocrinol Metab. 2018;103(7):2689–2697.